Shares of Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) shot up 4.9% on Friday . The stock traded as high as $210.80 and last traded at $210.80. 100 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 2,180 shares. The stock had previously closed at $201.00.
Sartorius Stedim Biotech Stock Performance
The firm has a 50-day moving average of $198.25 and a 200 day moving average of $210.62.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell‐ and gene‐based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.
Key product offerings include single‐use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.
Further Reading
- Five stocks we like better than Sartorius Stedim Biotech
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Sartorius Stedim Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Stedim Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
